WAVEMAN · COMPANY

GRNQ · Greenpro Capital Corp.

LIVE

TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475

← ALL COMPANIES

GRNQ

Name: Greenpro Capital Corp. (GRNQ) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

Greenpro Capital Corp.

PHARMA & BIOTECH · SERVICES-MANAGEMENT CONSULTING SERVICES · CIK 0001597846

C-SUITE BUYING · 1☆ WATCH

INSIDER NET · 180D

$400.1K

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

13F, latest reported quarter

REVENUE GROWTH

-40.7%

XBRL, annual

NET MARGIN

-143.8%

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net +$400.1K over 180 days

+$100.0K over 90 days · +$400.1K of it by a 10%+ holder

more than 83% of Pharma & Biotech

CONGRESS

no member of Congress has reported trading it

FUNDS

4 funds added or opened last quarter

REVENUE

-40.7% year over year

below 81% of Pharma & Biotech

MARGIN

-143.8% net margin

below 69% of Pharma & Biotech

BUYBACKS

no share repurchases reported

SHORT

0.1% of shares outstanding short · 1.9 days to cover · settled 2026-07-31

below 89% of Pharma & Biotech

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN +1631.5%

+1631.5%12M

INSIDER SELL

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

Insiders are net buyers of their own stock.

The record shows a net $400.1K bought by insiders over 180 days, 4 funds added last quarter. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

UTHR CPIX MRNA REGN LLY ALNY ELF CITR MDGL DNA VRTX NUVL

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Greenpro Capital Corp. insiders bought a net $400.1K of stock across 4 Form 4 purchases and sales, with 1 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER

FILED

VALUE

LEE CHONG KUANG

Chief Executive Officer

BUY

2026-06-30

65,591.0

$100.0K

LEE CHONG KUANG

Chief Executive Officer

BUY

2026-05-29

28,949.0

$50.1K

LEE CHONG KUANG

Chief Executive Officer

BUY

2026-04-28

107,310.0

$250.0K

LOKE CHE CHAN GILBERT

Chief Financial Officer

SELL

2021-12-07

385,000.0

$385.0K

4 TRANSACTIONS ON RECORD · THIN RECORD, READ IT AS SUCH

Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

GEODE CAPITAL MANAGEMENT, LLC

80,101.0 sh

$122.6K

CITADEL ADVISORS LLC

59,224.0 sh

$90.6K

UBS Group AG

1,194.0 sh

$1.8K

SBI Securities Co., Ltd.

1,000.0 sh

$1.5K

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

Fidelity Nasdaq Composite Index ETF

$135.2K POSITION · AS OF 2026-02-28

0.0%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$2.1M	$3.5M	$3.5M	$3.7M
GROSS PROFIT	$1.7M	$3.1M	$2.9M	$2.7M
OPERATING INCOME	$-2.2M	$-969.3K	$-1.5M	$-1.5M
NET INCOME	$-3.0M	$-715.3K	$1.1M	$-6.4M
EPS (DILUTED)	-0.37	-0.09	0.14	-0.81
OPERATING CASH FLOW	$-1.8M	$-1.4M	$-1.6M	$-2.4M
CASH	$636.7K	$1.1M	$2.2M	$3.9M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE